Revolutionary CAR-T Therapy: A Game-Changer for Autoimmune Diseases

Engineered immune cells known as CAR-T cells have shown promising results in treating autoimmune disorders such as lupus, systemic sclerosis, and idiopathic inflammatory myositis. In a study presented at the American Society of Hematology meeting, 15 participants remained disease-free or nearly so since their CAR-T cell therapy treatment. CAR-T therapy, which involves genetically engineering T cells to target and destroy abnormal B cells, has the potential to revolutionize the treatment of various conditions fueled by rogue immune cells. However, further research is needed to determine the specific contribution of CAR-T therapy versus chemotherapy in achieving these positive outcomes.